Effective Oral Favipiravir (T-705) Therapy Initiated after the Onset of Clinical Disease in a Model of Arenavirus Hemorrhagic Fever
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effective Oral Favipiravir (T-705) Therapy Initiated after the Onset of Clinical Disease in a Model of Arenavirus Hemorrhagic Fever
Authors
Keywords
-
Journal
PLoS Neglected Tropical Diseases
Volume 5, Issue 10, Pages e1342
Publisher
Public Library of Science (PLoS)
Online
2011-10-12
DOI
10.1371/journal.pntd.0001342
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In Vitro Antiviral Activity of Favipiravir (T-705) against Drug-Resistant Influenza and 2009 A(H1N1) Viruses
- (2010) K. Sleeman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Review of the Literature and Proposed Guidelines for the Use of Oral Ribavirin as Postexposure Prophylaxis for Lassa Fever
- (2010) Daniel G. Bausch et al. CLINICAL INFECTIOUS DISEASES
- Assessing changes in vascular permeability in a hamster model of viral hemorrhagic fever
- (2010) Brian B Gowen et al. Virology Journal
- T Cell-Dependence of Lassa Fever Pathogenesis
- (2010) Lukas Flatz et al. PLoS Pathogens
- Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease models
- (2009) Brian B. Gowen et al. ANTIVIRAL RESEARCH
- Development of Infectious Clones for Virulent and Avirulent Pichinde Viruses: a Model Virus To Study Arenavirus-Induced Hemorrhagic Fevers
- (2009) S. Lan et al. JOURNAL OF VIROLOGY
- T-705 (favipiravir) activity against lethal H5N1 influenza A viruses
- (2009) M. Kiso et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Risk Maps of Lassa Fever in West Africa
- (2009) Elisabeth Fichet-Calvet et al. PLoS Neglected Tropical Diseases
- Genetic Detection and Characterization of Lujo Virus, a New Hemorrhagic Fever–Associated Arenavirus from Southern Africa
- (2009) Thomas Briese et al. PLoS Pathogens
- Activity of T-705 in a Hamster Model of Yellow Fever Virus Infection in Comparison with That of a Chemically Related Compound, T-1106
- (2008) J. G. Julander et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodents
- (2008) J MORREY et al. ANTIVIRAL RESEARCH
- Cytokine patterns in a comparative model of arenavirus haemorrhagic fever in guinea pigs
- (2008) E. P. Scott et al. JOURNAL OF GENERAL VIROLOGY
- Targeting inside-out phosphatidylserine as a therapeutic strategy for viral diseases
- (2008) M Melina Soares et al. NATURE MEDICINE
- Treatment of Late Stage Disease in a Model of Arenaviral Hemorrhagic Fever: T-705 Efficacy and Reduced Toxicity Suggests an Alternative to Ribavirin
- (2008) Brian B. Gowen et al. PLoS One
- Chapare Virus, a Newly Discovered Arenavirus Isolated from a Fatal Hemorrhagic Fever Case in Bolivia
- (2008) Simon Delgado et al. PLoS Pathogens
- Animal models of highly pathogenic RNA viral infections: Hemorrhagic fever viruses
- (2007) Brian B. Gowen et al. ANTIVIRAL RESEARCH
- Treatment of Argentine hemorrhagic fever
- (2007) Delia A. Enria et al. ANTIVIRAL RESEARCH
- Dose translation from animal to human studies revisited
- (2007) Shannon Reagan-Shaw et al. FASEB JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started